Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

Treatments for hair loss vary, but cell-based options may be the future.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Caffeine in cosmetics may reduce cellulite, protect skin, and stimulate hair growth, but more research is needed on its use and effects.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Glioblastoma cells can make androgens, which might help the tumor grow.

Oral ivermectin effectively cured scabies with minimal side effects, and finasteride promoted hair growth in men with hair loss.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Transplant patients often get skin problems, with treatments varying by condition.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

DHT, a testosterone byproduct, causes male pattern baldness.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Better hair loss models needed for research.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

No clear link between finasteride use and acute pancreatitis risk.